CVS Health (NYSE:CVS) Price Target Raised to $118.00

CVS Health (NYSE:CVS) had its target price upped by analysts at JPMorgan Chase & Co. from $111.00 to $118.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the pharmacy operator’s stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 26.22% from the stock’s previous close.

CVS has been the topic of several other research reports. HSBC reiterated a “hold” rating and issued a $103.00 price objective on shares of CVS Health in a research note on Monday, July 6th. Cantor Fitzgerald increased their price target on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 7th. TD Cowen lifted their price target on shares of CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research report on Thursday, August 6th. Finally, Truist Financial raised their target price on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $106.75.

CVS Health Stock Performance

Shares of CVS traded down $0.01 during trading hours on Wednesday, hitting $93.49. The stock had a trading volume of 449,127 shares, compared to its average volume of 8,436,496. The firm has a market capitalization of $119.57 billion, a PE ratio of 24.78, a PEG ratio of 0.91 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health has a 12 month low of $65.26 and a 12 month high of $110.68. The stock has a fifty day moving average price of $102.43 and a 200 day moving average price of $88.00.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts anticipate that CVS Health will post 8.02 EPS for the current year.

Insider Activity at CVS Health

In related news, Director Larry Robbins sold 370,462 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $93.45, for a total value of $34,619,673.90. Following the sale, the director directly owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. The trade was a 7.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 3,372,000 shares of company stock valued at $317,473,598 in the last quarter. 0.85% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CVS Health

Several institutional investors have recently bought and sold shares of the business. Elevation Wealth Partners LLC boosted its position in CVS Health by 41.8% in the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 105 shares during the last quarter. Apella Capital LLC raised its position in CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after buying an additional 117 shares during the last quarter. CYBER HORNET ETFs LLC lifted its stake in CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock valued at $259,000 after acquiring an additional 134 shares during the period. LS Investment Advisors LLC boosted its holdings in shares of CVS Health by 3.9% in the 4th quarter. LS Investment Advisors LLC now owns 3,575 shares of the pharmacy operator’s stock valued at $284,000 after acquiring an additional 135 shares during the last quarter. Finally, Moss Adams Wealth Advisors LLC increased its stake in shares of CVS Health by 4.7% in the fourth quarter. Moss Adams Wealth Advisors LLC now owns 3,016 shares of the pharmacy operator’s stock worth $239,000 after acquiring an additional 135 shares during the period. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.